Rexulti (brexpiprazole) is a brand-name drug prescribed for certain mental health conditions. Rexulti comes as an oral tablet that’s typically taken once per day. The dosage can vary depending on what ...

Four years after gaining FDA approval for Auvelity to treat major depressive disorder (MDD), Axsome Therapeutics has tacked ...

Further, taking Rexulti during the third trimester of pregnancy may increase the risk of withdrawal symptoms in infants exposed to the drug. Withdrawal symptoms can include: difficulty breathing or ...

Credit: Getty Images. Brexpiprazole is an atypical antipsychotic. The Food and Drug Administration (FDA) has approved Rexulti ® (brexpiprazole) for the treatment of agitation associated with dementia ...

Rexulti (brexpiprazole) is a medication used to treat conditions like major depressive disorder (MDD), schizophrenia, and agitation associated with Alzheimer’s disease. Many Medicare Part D and ...

The FDA has ruled a claim that Otsuka made again and again overstates the efficacy of Rexulti. While Otsuka, which spends big on Rexulti TV spots, has repeatedly claimed its product is proven to ...

(RTTNews) - The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Poster data presented here at Psych Congress indicated three dosages of Rexulti improved ...